Response to: Enhancing Clinical Practice: Critical Insights for Medical Workers in Applying Pembrolizumab for Metastatic NSCLC and Pembrolizumab, Chemotherapy and Metastatic Non-Small Cell Lung Cancer

Authors

Shirish M. Gadgeel, Henry Ford HealthFollow
Erin Jensen
Mark Shamoun
Kumar Rajagopalan

Recommended Citation

Gadgeel SM, Jensen E, Shamoun M, and Rajagopalan K. Response to: Enhancing Clinical Practice: Critical Insights for Medical Workers in Applying Pembrolizumab for Metastatic NSCLC and Pembrolizumab, Chemotherapy and Metastatic Non-Small Cell Lung Cancer. J Thorac Oncol 2025; 20(1):e11-e12.

Document Type

Article

Publication Date

1-1-2025

Publication Title

J Thorac Oncol

PubMed ID

39794106

Volume

20

Issue

1

First Page

11

Last Page

11